What is the NGL Fine-Chem PE ratio today?
NGL Fine-Chem's PE ratio is 28.2 at the 29 October 2026 close (₹2,612.80 a share): a market capitalisation of ₹1,614 crore divided by consolidated net profit of ₹57.2 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹48.1 crore) it is 33.5.
What is the NGL Fine-Chem debt to equity ratio?
NGL Fine-Chem's debt-to-equity ratio was 0.33 on 31 March 2026: borrowings of ₹108 crore against total equity of ₹329 crore. A year earlier, on 31 March 2025, it was 0.26.
What is the NGL Fine-Chem net worth?
NGL Fine-Chem's net worth — shareholders' equity in its consolidated balance sheet — was ₹329 crore on 31 March 2026, up 16.6% from ₹282 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,614 crore at the 29 October 2026 close.
What is the NGL Fine-Chem PB ratio (price to book value)?
NGL Fine-Chem's price-to-book (PB) ratio is 4.90 at the 29 October 2026 close: a market capitalisation of ₹1,614 crore divided by shareholders' equity (book value) of ₹329 crore on 31 March 2026. That is a book value of ₹532.91 per share against a share price of ₹2,612.80.
What is the NGL Fine-Chem ROE and ROCE?
In FY26, NGL Fine-Chem's return on equity (ROE) was 15.7% and its return on capital employed (ROCE) was 15.0%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 7.8% and ROCE 7.3%.
What is the NGL Fine-Chem book value per share?
NGL Fine-Chem's book value per share was ₹532.91 on 31 March 2026: shareholders' equity of ₹329 crore divided by the 61.78 lakh shares in issue, up 16.6% from ₹457.16 a year earlier. The share price at the 29 October 2026 close was ₹2,612.80.
What is the NGL Fine-Chem market cap?
NGL Fine-Chem's market capitalisation was ₹1,614 crore at the 29 October 2026 close: 61.78 lakh shares at ₹2,612.80 each.
What is the NGL Fine-Chem EPS?
NGL Fine-Chem's basic earnings per share (EPS) were ₹77.90 in FY26, against ₹34.19 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹92.59.
What is the NGL Fine-Chem dividend in 2026 and its record date?
In 2026, NGL Fine-Chem has declared one dividend: ₹1.75 with record date 18 August 2026.
Is NGL Fine-Chem debt free?
No. NGL Fine-Chem had borrowings of ₹108 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.33. Its cash and current investments were ₹44.3 crore, so its net debt was ₹64.1 crore.
What is the NGL Fine-Chem promoter holding?
Promoters held 72.49% of NGL Fine-Chem on 30 September 2026, unchanged from the previous quarter and down 0.25 percentage points from 72.74% a year earlier, according to the shareholding pattern filed with NSE.
When are the NGL Fine-Chem next results?
NGL Fine-Chem has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
What is the NGL Fine-Chem dividend yield?
NGL Fine-Chem's dividend yield is 0.07% at the 29 October 2026 close: dividends of ₹1.75 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹2,612.80. They were ₹1.75 on 18 August 2026.
What is the NGL Fine-Chem free cash flow?
In FY26, NGL Fine-Chem generated ₹43.3 crore of cash from operations and spent ₹89.9 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹46.5 crore. In FY25 it was −₹94.9 crore.
What are the NGL Fine-Chem latest quarterly results?
NGL Fine-Chem's latest results are for Q1 FY27 (April–June 2026), filed on 12 August 2026: consolidated net profit ₹18.4 crore, up 99.1% from ₹9.2 crore in Q1 FY26; revenue from operations ₹139 crore, up 33.6% year on year.
What is the NGL Fine-Chem shareholding pattern?
On 30 September 2026, NGL Fine-Chem's shares were held by promoters 72.49%, foreign portfolio investors (FII/FPI) 0.04%, domestic institutions (DII) 0.00% (including mutual funds at 0.00%) and retail and other non-institutional investors 27.46%. Over the year, FII holding was up 0.04 percentage points from 0.00%.
What is the NGL Fine-Chem revenue and profit in FY26?
In FY26 (April 2025–March 2026), NGL Fine-Chem's consolidated net profit was ₹48.1 crore, up 127.8% from ₹21.1 crore in FY25, on revenue from operations of ₹501 crore (up 36.0%). Over three years, from FY23, net profit was up 134.8%.
How does the NGL Fine-Chem PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit, NGL Fine-Chem's PE ratio is 33.5, the third highest of the four: Syncom Formulations 25.1, Jagsonpal Pharmaceuticals 34.3 and Hester Biosciences 35.3, a peer average of 31.6. Each is the company's market capitalisation at that price divided by its FY26 net profit.
How does NGL Fine-Chem compare with its peers?
On FY26 consolidated figures, against Syncom Formulations, Jagsonpal Pharmaceuticals and Hester Biosciences: NGL Fine-Chem's operating margin of 10.6% is the lowest of the four (Syncom Formulations 14.5%, Jagsonpal Pharmaceuticals 16.9%, Hester Biosciences 20.4%; peer average 17.3%); its return on equity of 15.7% is the lowest of the four (Syncom Formulations 20.2%, Jagsonpal Pharmaceuticals 16.7%, Hester Biosciences 16.5%; peer average 17.8%); its revenue growth over three years of 21.7% a year is the second highest of the four (Syncom Formulations 29.7% a year, Jagsonpal Pharmaceuticals 6.7% a year, Hester Biosciences 7.7% a year; peer average 14.7% a year).
NGL Fine-Chem vs Syncom Formulations: how do they compare?
In FY26, NGL Fine-Chem earned net profit of ₹48.1 crore on revenue of ₹501 crore, against ₹76.4 crore on ₹489 crore for Syncom Formulations. NGL Fine-Chem's operating margin was 10.6% (Syncom Formulations 14.5%) and its return on equity 15.7% (Syncom Formulations 20.2%). At the 29 October 2026 close, NGL Fine-Chem's market capitalisation was ₹1,614 crore against ₹1,919 crore for Syncom Formulations, and its PE ratio on FY26 profit 33.5 against 25.1.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
